Melanoma: all 3,073 studies
Page 26 of 31. Open to participants first (529), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess PV-10 Chemoablation of Cancer of the LiverStatus unknownNCT00986661Phase 1
- Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic MelanomaCompletedNCT00984464Phase 2
- Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV MelanomaWithdrawnNCT00979693Phase 2
- Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant MelanomaCompletedNCT00978913Phase 1
- Evaluating the Safety and the Biological Effects of Intratumoral Interferon Gamma and a Peptide-Based Vaccine in Patients With MelanomaTerminatedNCT00977145Phase 1
- Neurotropic Melanoma of the Head and NeckCompletedNCT00975520Not applicable
- Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.CompletedNCT00974610
- Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for MelanomaCompletedNCT00972933Early Phase 1
- Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic MelanomaCompletedNCT00970996Phase 1
- International Melanoma Algorithm Training Study - IMATSCompletedNCT00966173Not applicable
- SCRI Tissue Testing RegistryTerminatedNCT00965861
- Evaluation of Interferon-Lovastatin Therapy for Malignant MelanomaWithdrawnNCT00963664Phase 2
- Quality of Life and Psychological Well-being in Patients With Malignant MelanomaStatus unknownNCT00963261Not applicable
- Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by SurgeryCompletedNCT00962845Early Phase 1
- Trial for Vaccine Therapy With Dendritic Cells in Patients With Metastatic Malignant MelanomaTerminatedNCT00961844Phase 1/2
- Vaccination of Melanoma Patients With Total or CD25-depleted Peripheral Blood Mononuclear Cell (PBMC)TerminatedNCT00961376Phase 2
- Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the EyeCompletedNCT00952939
- Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic CellsCompletedNCT00948480Phase 2
- Study of TAK-733 in Adult Patients With Advanced Nonhematologic MalignanciesCompletedNCT00948467Phase 1
- Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV MelanomaTerminatedNCT00945269Phase 1/2
- Toll-like Receptor (TLR) Ligand Matured Dendritic Cell Vaccination in Melanoma PatientsCompletedNCT00940004Phase 1/2
- Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced MelanomaCompletedNCT00938223Phase 2
- Study of Tumor Tissue From Patients With Melanoma Treated on Clinical Trial EST-1690CompletedNCT00937781
- Pilot Study of Infrared Imaging of Cutaneous MelanomaCompletedNCT00937690
- T-cell Based Immunotherapy for of MelanomaCompletedNCT00937625Phase 1/2
- Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma PatientsTerminatedNCT00929019Phase 1/2
- Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk MelanomaCompletedNCT00928902Phase 2
- Long-term Data Collection for Subjects in MDX-010 StudiesCompletedNCT00928031
- A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III MelanomaStatus unknownNCT00925314Phase 2
- Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)CompletedNCT00923169Phase 1
- A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for MelanomaCompletedNCT00912730
- Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38CompletedNCT00912574Not applicable
- Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) - in - Adjuvant, Followed by Systemic Low-dose-interleukin-2 (IL-2) Administration, in Patients With High Risk MelanomaCompletedNCT00912418Not applicable
- Sun Exposure and Melanoma in Agricultural WorkersCompletedNCT00901966
- S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic MelanomaCompletedNCT00898183
- Bone Marrow and Blood Samples From Patients With Metastatic Choroid MelanomaCompletedNCT00897624
- Biomarkers to Predict Response to Interferon Therapy in Patients With MelanomaCompletedNCT00897546
- Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon TherapyCompletedNCT00897520
- Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node BiopsyStatus unknownNCT00897481
- Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn DiseaseTerminatedNCT00897312
- Melanoma Molecular Profiling AnalysisCompletedNCT00889980
- Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic MelanomaCompletedNCT00881049Phase 2
- Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal MelanomaStatus unknownNCT00872391Not applicable
- Pilot Study of IFN α2b for Melanoma PatientsTerminatedNCT00871533Early Phase 1
- Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic MelanomaCompletedNCT00871481Phase 1/2
- Immunohistochemical Expression Patterns of microRNA Processing Enzyme Dicer in Cutaneous Malignant Melanoma, Benign and Dysplastic Melanocytic NaeviCompletedNCT00862914
- Adjuvant Therapy of Pegylated Interferon- 2b Plus Melanoma Peptide VaccineCompletedNCT00861406Phase 1
- Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid TumorsCompletedNCT00855452Phase 2
- Genetic Risk Factors and Acquired Oncogenic Mutations of MelanomaStatus unknownNCT00849407
- Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma PatientsCompletedNCT00847106Phase 1/2
- Haploidentical NK Cell Infusion in Malignant MelanomaCompletedNCT00846833Phase 1/2
- Safety and Tolerability of AP 12009, Administered I.V. in Patients With Advanced Tumors Known to Overproduce TGF-beta-2CompletedNCT00844064Phase 1
- Multicentric Cohort of Melanoma Patients in Ile de France AreaCompletedNCT00839410
- Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 ExpressionCompletedNCT00835419Phase 2
- Collecting Blood and Tissue Samples From Family Members of Patients With Pancreatic Diseases, Pancreatic Cancer, and MelanomaActive, not recruitingNCT00835133
- Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the LiverCompletedNCT00833807Phase 1
- The Response of Serum 25-Hydroxyvitamin D to Incidental Ultraviolet Light ExposureCompletedNCT00832533
- Study to Evaluate the Efficacy and Safety of Temozolomide in Subjects With Brain Metastases of Either Malignant Melanoma, Breast, or Non-small Cell Lung Cancer (P02064)CompletedNCT00831545Phase 2
- PET-CT in the Management of Patients With Stage III or IV Metastatic MelanomaCompletedNCT00828126
- Comparison of Video-Based Versus Written Patient Education on MelanomaCompletedNCT00826995Not applicable
- An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155CompletedNCT00818480Phase 2
- Tailored Intervention for Melanoma Patient's FamiliesCompletedNCT00816374Not applicable
- Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV MelanomaCompletedNCT00815607Phase 1
- Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced MelanomaStatus unknownNCT00813449Phase 2
- Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV MelanomaStatus unknownNCT00811759Phase 1/2
- Treatment Of Radiation Retinopathy TrialStatus unknownNCT00811200Phase 2/3
- Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)CompletedNCT00809588Phase 1
- Combination of Anti-CD137 & Ipilimumab in Patients With MelanomaWithdrawnNCT00803374Phase 1
- Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells MaturedCompletedNCT00798629Phase 1
- Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and DacarbazineCompletedNCT00794235Phase 2
- Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I PortionTerminatedNCT00791271Phase 1
- Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV MelanomaCompletedNCT00790010Phase 1
- In Vivo Confocal Microscopy for Pigmented Lesion DiagnosisCompletedNCT00785369Not applicable
- Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTICStatus unknownNCT00779714Phase 3
- Feasibility and Functionality of fPAM Imaging in MelanomaTerminatedNCT00776945
- Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone MetastasesWithdrawnNCT00769990Phase 1/2
- Ranibizumab in Combination With Proton Beam Irradiation for Choroidal MelanomaCompletedNCT00765921Phase 1
- A Novel Treatment for Metastatic MelanomaTerminatedNCT00758797Phase 1
- Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United KingdomStatus unknownNCT00757614
- Sulindac and Epirubicin in Treating Patients With Metastatic Malignant MelanomaCompletedNCT00755976Phase 2
- Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal MelanomaCompletedNCT00750399Phase 1
- Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic MelanomaTerminatedNCT00747825Phase 1
- A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced MelanomaStatus unknownNCT00746746Phase 2
- Illness Related Distress in Women With Clinically Localized Cutaneous MelanomaCompletedNCT00745862
- A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and MelanomaCompletedNCT00743496Phase 1
- Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5CompletedNCT00743353Early Phase 1
- Efficacy Study of TLN-232 in Patients With Recurring Metastatic MelanomaTerminatedNCT00735332Phase 2
- Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic MelanomaCompletedNCT00734188Phase 1
- A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant MelanomaTerminatedNCT00733798Phase 1/2
- Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant MelanomaCompletedNCT00729950Phase 1
- A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic MelanomaTerminatedNCT00724841Phase 1/2
- Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma PatientsTerminatedNCT00722098Phase 2
- Treatment of Metastatic Melanoma With Autologous Melan-A/MART-1 Specific CTL ClonesCompletedNCT00720031Phase 1/2
- Nausea and Vomiting In Patients Receiving Consecutive Days of CisplatinTerminatedNCT00716560
- Safety and Pharmacodynamic Study of a New Formulation, AGI - 101H Vaccine in the Treatment of Advanced MelanomaTerminatedNCT00716495Phase 1/2
- Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid MalignanciesCompletedNCT00710515Phase 1
- Vaccine Therapy in Treating Patients With Advanced MelanomaCompletedNCT00705640Phase 1
- Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic MelanomaStatus unknownNCT00701987Phase 1
- Immune Responses To Antigen-Bearing Dendritic Cells in Patients With MalignancyCompletedNCT00700167Phase 1
- Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA VaccinesCompletedNCT00698100Phase 1